官方服务：
资源简介：
Supplemental Table 1 for, "Methotrexate for pyoderma gangrenosum: a retrospective case series of 33 patients"
应用场景：
创建时间：
2023-10-31
相关数据集
Methotrexate for PG: Supplemental Table
Supplemental Table for the article, "Methotrexate for pyoderma gangrenosum: a retrospective case series of 33 patients" by Josiah A. Williams, MD; Matthew L. Hrin, MD; Nathan L. Bowers, MD, PhD; Josep
Mendeley Data2024-01-31 更新180
Supplementary Material for: Pyoderma Gangrenosum and Interleukin Inhibitors: A Semi-Systematic Review
Background: Pyoderma gangrenosum (PG) is a rare ulcerating skin disease associated with multiple comorbidities and increased mortality. In recent decades, newer biologics such as interleukin inhibitor
NIAID Data Ecosystem90
Serious adverse events (SAE) in patients while using methotrexate (first and later courses).
Serious adverse events (SAE) in patients while using methotrexate (first and later courses).
Figshare2018-03-23 更新70
The role of GSK3 on macrophage re-programming by high-dose methotrexate. The role of GSK3 on macrophage re-programming by high-dose methotrexate
Macrophage phenotypic and functional heterogeneity derives from tissue-specific transcriptional signatures shaped by the local microenvironment. M-CSF drives the generation of human monocyte-derived m
NIAID Data Ecosystem150
Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review - Supplemental Material
Supplemental material for 'Clinical Manifestations and Treatment Outcomes of Pyoderma Gangrenosum on Rituximab Therapy: A Systematic Review'. Each file corresponds to a supplementary table referenced
NIAID Data Ecosystem80
